Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 4,355.00
0.00 (0.00%)
At close: May 4, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 428.66 billion as of May 5, 2026. Its market cap has increased by 383.58% in one year.
Market Cap
428.66B
Enterprise Value
373.45B
Revenue
29.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,355.00
Market Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 428.66B, an increase of 469.14%. That is a compound annual growth rate of 18.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 428.66B | 177.36% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 429.10B |
| Inventera | 167.93B |
| GENINUS | 165.84B |
| Cytogen | 136.11B |
| HLB Panagene | 96.63B |
| Green Cross Medical Science | 84.03B |
| Protia | 64.51B |
| Seoulin Bioscience | 55.96B |